Literature DB >> 19277967

The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography.

Erzsébet Gere-Pászti1, Judit Jakus.   

Abstract

The amphetamine (AMPH)-induced alteration in rat brain dopamine levels modified by N-acetylcysteine (NAC) administration has been examined using isocratic ion-pair reversed-phase high-performance liquid chromatography with electrochemical detection. The aim of the development of a novel validated evaluation scheme implying a double AMPH challenge was to enhance the efficiency of AMPH-triggered dopamine release measurements in rat brain striatal slices by improving the reproducibility of the results. The proposed experimental protocol was tested in vivo and proved to be capable of fast and reliable drug screening for tracing the effect of NAC as a model compound in AMPH-mediated dopaminergic response. The subcellular localization of the dopamine mobilizing effect of NAC has been established indirectly by the use of an irreversible dopamine vesicular depletor, reserpine. The antioxidant NAC at 10 mM plays an important role in the complete suppression of acute AMPH-elicited dopamine release. The possible role of this quenching effect is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277967     DOI: 10.1002/bmc.1171

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  11 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Signaling Mechanisms in the Nitric Oxide Donor- and Amphetamine-Induced Dopamine Release in Mesencephalic Primary Cultured Neurons.

Authors:  Cristiane Salum; Fanny Schmidt; Patrick P Michel; Elaine Del-Bel; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2015-09-21       Impact factor: 3.911

Review 3.  N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Authors:  Olivia Dean; Frank Giorlando; Michael Berk
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

4.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

5.  Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects.

Authors:  Marwa M Al-Samhari; Nouf M Al-Rasheed; Salim Al-Rejaie; Nawal M Al-Rasheed; Iman H Hasan; Ayman M Mahmoud; Nduna Dzimiri
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-06

Review 6.  Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Amir Ghaderi; Anna Bussu; Catherine Tsang; Sadegh Jafarnejad
Journal:  Eur J Clin Pharmacol       Date:  2018-11-16       Impact factor: 2.953

Review 7.  N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.

Authors:  Reza Bavarsad Shahripour; Mark R Harrigan; Andrei V Alexandrov
Journal:  Brain Behav       Date:  2014-01-13       Impact factor: 2.708

8.  Neuroprotective Role of N-acetylcysteine against Learning Deficits and Altered Brain Neurotransmitters in Rat Pups Subjected to Prenatal Stress.

Authors:  Liegelin Kavitha Bernhardt; K Lakshminarayana Bairy; Sampath Madhyastha
Journal:  Brain Sci       Date:  2018-06-28

9.  N-Acetylcysteine as a novel rapidly acting anti-suicidal agent: A pilot naturalistic study in the emergency setting.

Authors:  Davinder Hans; Anthony Rengel; Jaspreet Hans; Darryl Bassett; Sean Hood
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.240

Review 10.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.